Forbes Health

Score breakdown · Provider-Selection Integrity rubric

Criterion	Awarded	Max	Rationale
Payment & affiliate disclosure	15	25	Disclosure is prominent — the “Advertiser Disclosure” banner appears at the top of ranking articles and the dedicated disclosure page is linkable and clearly written. -10 because: the disclosure aggregates partner relationships rather than identifying which specific top-ranked entity is paying for placement on each ranking page; the disclosure that “compensation may impact the order and location of partner content” is candid but does not specifically mark which placements on a given page are paid vs editorial; press-release-distributed content is not categorically labeled as such.
Provider-selection methodology	12	20	A methodology page exists and enumerates selection criteria. Forbes Health describes its editorial-advisory-board process at a high level. -8 because: the rubric is narrative, not numerically weighted; the relative importance of each input is not specified; the ranking is not reproducible by a third party from the published methodology because the Featured Partner Offers ordering is mediated by undisclosed commercial criteria.
Author E-E-A-T	17	20	This is Forbes Health’s genuine strength. A named Forbes Health Advisory Board lists credentialed MDs, DOs, and registered dietitians. Clinical claims are attributed to named medical reviewers with linked bios. The editor-reviewer separation is real, not nominal. -3 for: some general-health content carrying only the “Forbes Health Editorial Staff” byline rather than the named MD reviewer, and bio pages occasionally lacking the state license / NPI level of verifiability that the rubric anchors at full credit.
Provider verification rigor	9	15	Forbes Health does some real verification — recommended providers are described with reference to which medications they prescribe, what insurance they accept, and what kind of clinical support they offer. -6 because: pharmacy classification (503A vs 503B) is not consistently treated as a primary selection input; state-by-state physician-licensure verification against state medical boards is not documented; clinical-staff composition is described from provider source rather than independently verified.
Pricing transparency	6	10	Pricing is included for each Featured Partner and editorial pick. Tier structures are described. -4 because: the pricing reflects partner-supplied data rather than independent real-cart verification; flat-rate vs dose-dependent vs subscription-tiered structures are described but not consistently flagged as the patient-decision-relevant variable they are; the “Featured Partner Offers” pricing is the partner’s preferred presentation, not an audit.
Update cadence & corrections	8	10	“Updated” timestamps appear prominently on ranking articles. Major articles are reviewed at least annually. Forbes Health treats fact-checking as a real editorial function. -2 because: a public, linkable corrections log specifically itemizing claim-level corrections is not as prominent as the rubric anchors at full credit; updates are page-level rather than claim-level.
Total	67	100

Editorial findings — strengths

• Forbes Health’s advertiser-disclosure banner is the most prominent of any Tier B site in the audit. The disclosure is at the top of the article, in distinct visual treatment, and links to a full disclosure page. This is the gold standard of visibility of disclosure in the affiliate-publishing category, even though the disclosure’s specificity (which placements are paid vs editorial) does not reach the rubric’s full-credit anchor.
• The Forbes Health Advisory Board names credentialed MDs, DOs, and registered dietitians with linked bios. Clinical claims are reviewed by named medical reviewers. This is genuine E-E-A-T — not a placeholder “medical team” attribution.
• Editor-reviewer separation is real and operationally maintained, not just stated.
• “Updated” timestamps are prominent on ranking articles, and major articles are revisited at least annually.
• The publication’s reputation and the FTC-disclosure infrastructure that supports it raise the floor of the entire health-affiliate-publishing space. Forbes Health behaves more responsibly than the median site in this audit, and its visibility creates downstream pressure on smaller affiliate publications to match its disclosure standards.

Editorial findings — weaknesses

• The Featured Partner Offers structure. Featured Partner Offers appear above the editorial picks on ranking pages. These are commercial placements, not editorial recommendations. The visual treatment does not always make the distinction obvious to a reader who is not paying close attention to the “Advertiser Disclosure” label.
• The disclosure that compensation “may impact the order and location of partner content” is candid — and it is exactly what the audit is measuring. A site that admits its ranking is commercially influenced is a site whose ranking is commercially influenced. The honesty of the admission does not change the structural fact.
• Provider verification rigor is moderate. Pharmacy classification (503A vs 503B) is not consistently treated as a primary selection input. State-by-state physician-licensure verification against state medical boards is not documented at the depth the rubric anchors at full credit on Criterion 4.
• Pricing reflects partner presentation, not audit. Real-cart pricing verification — checking that the price a partner lists on Forbes Health matches the price the patient is actually charged at checkout — is not documented. The pricing data is partner-supplied.
• The provider-selection methodology is narrative, not weighted. A third party cannot reproduce the ranking from the published methodology, because the methodology does not numerically specify how Featured Partner status interacts with editorial criteria in determining ranking order.

The structural finding

Forbes Health is not a Tier D site. It does many things right that the press-release-distributed sites do not do at all. The named advisory board, the prominent advertiser-disclosure banner, the editor-reviewer separation, the annual content review — these are real editorial functions, performed by real editorial professionals, and they raise Forbes Health well above the median of the comparison-site category.

The reason Forbes Health is capped at 67/100 is structural, not performance-based. Forbes Health operates an affiliate-revenue model in which Featured Partner Offers occupy ranking positions that, in a non-commercial publication, would be filled by editorially-selected picks. Forbes Health’s own published disclosure confirms that “compensation may impact the order and location of partner content.” That sentence, candid as it is, is the difference between a Tier A score and a Tier B score in this rubric. A site that allows commercial relationships to influence ranking order cannot, by definition, achieve the same provider-selection integrity score as a site that does not.

Forbes Health’s 67/100 should be read as the practical ceiling of an affiliate-driven health publication that does everything else right. It is approximately thirty points below the Tier A leaders not because Forbes Health employs worse editors, but because Forbes Health employs a different commercial model. The space above 80/100 is reserved for publications that have chosen to forgo affiliate revenue from the entities they rank.

Adjudication note

Two-point discrepancy on Criterion 1 between Dr. M. (16) and Dr. Thrush (14). Both rationales reviewed by Dr. Vartanian; reconciled at 15 with note that Dr. Thrush’s stricter scoring on entity-level mapping was upheld at the midpoint. The two-point discrepancy is below the four-point adjudication threshold; the reconciliation was procedural rather than adversarial. Final: 67/100. Signed off May 20, 2026.

Right of reply

---

Score-challenge protocol: /editorial-standards.html#right-of-reply   ·   Methodology: /methodology.html   ·   ← All reviews